Peter works in the commercial team at Synthace where he is passionate about how digital technology will widen patient access to new therapeutic modalities.
Prior to Synthace, he worked in a corporate healthcare investment role with a focus on deal origination and due diligence of novel therapeutic opportunities. He was also a founding member and a global director of an international start-up accelerator, and has spent time at the coal face within leading blue-chip biopharmaceutical R&D. Peter has spoken on topics pertinent to healthcare innovation at events across Europe and APAC, as well as at the Rio Paralympics. He also serves as an advisor on biotechnology & healthcare to Luminous Ventures, a pan EU Deep Tech VC fund.
Peter has a DPhil in Chemical Biology from Oxford University and an undergraduate master’s degree in Chemistry from Warwick University; where he graduated as the top ranked student.